No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
US Manufacturing Index Rises To 43, Highest Since 2020
TherapeuticsMD Third Quarter 2024 Earnings: US$0.049 Loss per Share (Vs US$0.13 Loss in 3Q 2023)
Therapeutics MD GAAP EPS of -$0.05
TherapeuticsMD Shifts Focus With Lower Q3 Losses
TherapeuticsMD | 10-Q: Q3 2024 Earnings Report
TherapeuticsMD | 8-K: TherapeuticsMD Announces Third Quarter 2024 Financial Results